Agonist Effects of Propranolol on Non-Tumor Human Breast Cells
Open Access
- 22 April 2020
- Vol. 9 (4), 1036
- https://doi.org/10.3390/cells9041036
Abstract
The β-blocker propranolol (PROP) has been proposed as a repurposed treatment for breast cancer. The similarity of action between β-agonists and antagonists found on breast cells encouraged us to compare PROP and isoproterenol (ISO, agonist) signaling pathways on a human breast cell line. Cell proliferation was measured by cell counting and DNA-synthesis. Cell adhesion was measured counting the cells that remained adhered to the plastic after different treatments. Changes in actin cytoskeleton were observed by fluorescence staining and Western Blot. ISO and PROP caused a diminution of cell proliferation and an increase of cell adhesion, reverted by the pure β-antagonist ICI-118551. ISO and PROP induced a reorganization of actin cytoskeleton increasing F-actin, p-COFILIN and p-LIMK. While ISO elicited a marked enhancement of cAMP concentrations and an increase of vasodilator-stimulated phosphoprotein (VASP) and cAMP response element-binding protein (CREB) phosphorylation, PROP did not. Clathrin-mediated endocytosis inhibition or β-arrestin1 dominant-negative mutant abrogated PROP-induced cell adhesion and COFILIN phosphorylation. The fact that PROP has been proposed as an adjuvant drug for breast cancer makes it necessary to determine the specific action of PROP in breast models. These results provide an explanation for the discrepancies observed between experimental results and clinical evidence.This publication has 56 references indexed in Scilit:
- Beta-adrenergic blocking drugs in breast cancer: a perspective reviewTherapeutic Advances in Medical Oncology, 2012
- Molecular Pathways: Beta-Adrenergic Signaling in CancerClinical Cancer Research, 2012
- β2-Adrenergic Receptor Agonists Modulate Human Airway Smooth Muscle Cell Migration via Vasodilator-Stimulated PhosphoproteinAmerican Journal of Respiratory Cell and Molecular Biology, 2012
- Involvement of α2‐ and β2‐adrenoceptors on breast cancer cell proliferation and tumour growth regulationBritish Journal of Pharmacology, 2011
- Multiple ligand-specific conformations of the β2-adrenergic receptorNature Chemical Biology, 2011
- β-Blocker drugs mediate calcium signaling in native central nervous system neurons by β-arrestin–biased agonismProceedings of the National Academy of Sciences of the United States of America, 2010
- β-Arrestins Scaffold Cofilin with Chronophin to Direct Localized Actin Filament Severing and Membrane Protrusions Downstream of Protease-activated Receptor-2Online Journal of Public Health Informatics, 2010
- Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heartAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- The small heat shock-related protein, HSP20, is a cAMP-dependent protein kinase substrate that is involved in airway smooth muscle relaxationAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signalingProceedings of the National Academy of Sciences of the United States of America, 2007